INTRODUCTION {#sec1}
============

Benign Prostatic Hyperplasia (BPH) is a common urologic disorder, which mostly affects elderly men \[[@cit0001]\]. This disorder can affect approximately 50% of men aged between 51 and 60 and also more than 70% of those over 70 years old \[[@cit0002], [@cit0003]\]. The two major impacts of BPH are the proliferations of smooth muscle and epithelial cells located in the prostate, which cause the urinary tract to narrow. While the BPH etiology is arguable, testosterone and dihydrotestosterone are widely known to be related to the development of BPH \[[@cit0004]\].

Among the several treatments available for this disorder are the medical and surgical ones. Finasteride administration is one of the most prevalent treatments for BPH. Finasteride is a type of steroid reductase inhibitor which causes a certain amount of decrease in the hormone dihydrotestosterone in the body. This induces the prostate gland to get smaller, which in turn helps relieve urinary problems. In addition to medical approaches, surgical treatments such as transurethral resection of the prostate, which is considered to be the standard method \[[@cit0005]\], laser therapy \[[@cit0006]\], open prostatectomy and other minimally invasive procedures are available \[[@cit0007]\]. The difficulties associated with these approaches are two-fold. Not only can some patients not tolerate surgery, but also all of these treatments involve other concerns such as high expense, orthostatic hypotension, ejaculation changes, headaches and nasal congestion \[[@cit0008]\].

One of the less invasive treatment methods of BPH is injection therapy. This involves the application of a variety of chemical compounds, including alcohol \[95%\], Lugol's solution, 5--10% of silver nitrate, and sodium hydroxide (10%), carbolic acid, glacial acetic acid, glycerin \[[@cit0009]\]. The majority of these compounds are reported to provoke some level of inflammatory reactions which ultimately lead to local coagulative necrosis \[[@cit0009]\]. Consequently, the prostate volume would reduce and this would result in different degrees of urethral syndrome relief. Previously, numerous cases have confirmed the safety and efficacy of ethanol and provide support for its application in BPH \[[@cit0009]\]. In an attempt to introduce other injectable agents, this study was conducted to compare bleomycin with ethanol injection and finasteride therapy. Bleomycin is a medication used to treat cases of cancer such as lymphomas, testicular and ovarian cancer. In order to remove cancer cells, bleomycin stimulates DNA strand breaks and also takes parts in lipid peroxidation and oxidation of other cellular molecules. Bleomycin has certain applications in dermatology and has been applied to treat various benign skin conditions including warts, hemangiomas, vascular malformations, telangiectasias as well as several types of cutaneous malignancies, condyloma acuminata, and the lesions of leishmaniasis cutis \[[@cit0010]\]. However, there have been few studies on its application in BPH treatment using a prostatic injection. Therefore, the aim of the present study was to evaluate and compare the effects of intraprostatic injection of ethanol 96%, bleomycin and oral administration of finasteride and the subsequent stereological changes in prostate tissue. Stereological methods can bring about quantitative, reliable and comparable data. This study aimed to answer the following questions: How much of the volume of the prostate and its components (glandular epithelium, fibromuscular tissue and microvessels) would increase after testosterone administration?Can intraprostatic injection of ethanol 96% reverse the increments of the prostatic structures in BPH rats? If so, by how much?Can the intraprostatic injection of bleomycin revert the growth of the prostatic structures in BPH animals? If so, by how much?Can the oral finasteride administration reverse the enhancement of the prostatic structures in BPH rats? If so, by how much?

MATERIAL AND METHODS {#sec2}
====================

Animals and interventions {#sec2.1}
-------------------------

In this study, we opted for a rat model consisting of thirty Sprague-Dawley rats with an average weight of 300 +/-50g, which were obtained from The Center of Comparative and Experimental Medicine of the University. The animal experiments were allowed and approved by the Vice Chancellor of the University. The rats were then randomly assigned to six equal groups (*n* = 5). Group I (control) consisted of normal rats which had neither BPH nor treatment. BPH was induced using intramuscular injection of testosterone (2 mg/day) for 4 consecutive weeks in group II--VI. Group II received no further treatments. Through gavage feeding, Group III also received 10 mg/kg/day finasteride for two weeks. Group IV--VI received ethanol (95%), bleomycin (5 mg/kg) and distilled water using direct injection to the ventral lobes of the prostate, respectively. The last three injections were single injections and performed at the end of the 4^th^ week. To perform the direct injection, the animal received Ketamine (70--100 ml/kg) and xylazine (6--10 ml/kg) intramuscularly to induce anesthesia. After the lower abdominal area was sectioned, the bladder was identified and the ventral prostate lobes were found at the base of bladder. Afterwards, ethanol, bleomycin and normal saline (25 mm^3^) were injected in the ventral lobe of prostate. This amount was 1/10 of the average volume of each ventral lobe of prostate (250 mm^3^), which was estimated in a pilot study. Then the surgical site was sutured using nylon 5/0 and the animals were returned to their corresponding cages for recovery. Two weeks after injections, all animals were scarified under deep anesthesia with ketamine and xylazine and this was followed by the extraction of ventral lobes of prostate tissue. The weight and the volume of ventral lobes were measured and then the tissue was fixed in buffered formalin for future stereological evaluations.

Stereological study {#sec2.2}
-------------------

The volume of the ventral lobes of prostate was estimated using the immersion method developed by Scherle \[[@cit0011]\]. Additionally, to estimate the volume density of the gland's epithelium, fibromuscular tissue and vessels, the sampled sections were examined using a videomicroscopy system. Systematic random sections of the prostate were prepared and embedded in one paraffin block. Four micrometer sections were prepared and stained with Heidenhain's AZAN trichrome stain. The field of view in each section was subsampled by systematic random sampling using the microscope's stage vernier. The volume density of the structures was estimated at final magnification of 80x using the point-counting method and the following formula \[[@cit0011]\]:

Vv (structure/prostate) = P(structure)/P(prostate) where 'P(structure)' indicates the number of points hitting the favored histological structures and P(prostate) is the number of points hitting the reference space, here whole prostatic sections. The absolute total volume of each structure was estimated by the volume density multiplied by the total volume of the prostate.

Statistical methods {#sec2.3}
-------------------

The data was analyzed using the Kruskal-Wallis and Mann-Whitney U tests. A value of P \<0.05 was considered to be significant.

RESULTS {#sec3}
=======

Quantitative evaluations {#sec3.1}
------------------------

The results of quantitative evaluations are presented in [Figure 1](#f0001){ref-type="fig"}. Broadly speaking, The volume of the ventral lobes of prostate, glandular epithelium, fibromuscular tissue and microvessles increased by 1.7, 3.1, 2.4 and 1.6 times respectively in testosterone-treated rats (BPH) in comparison to the control rats (P \<0.01). These findings indicate the hypertrophic effect of testosterone on the main histological structures of the prostate.

![Dot of the parameters in prostate of the rats. The total volume of the prostate's ventral lobe **(A),** glandular epithelium **(B),** fibromuscular tissue **(C)** and vessels **(D)** of the rats in the control group, and the testosterone-treated rats co-treated with no treatment, alcohol, bleomycin, finasteride and normal saline. Each dot represents the estimated parameter in an animal. Horizontal bar indicates the mean in each group.](CEJU-70-01211-g001){#f0001}

Injection of alcohol in the BPH rats brought about a devolution of the total volume of the ventral lobes, glandular epithelium and fibromuscular tissue as opposed to the BPH group (P \<0.01). In other words, the volume of the ventral lobes and fibromuscular tissue decreased substantially and even glandular epithelium was restored to the normal values of the control rats. In contrast, the volume of the microvessels increased significantly in alcohol+BPH group (3.5 folds) as compared to both the control group and even the BPH (P \<0.01). In short, injection of alcohol clearly recovered the hypertrophic change of the prostate.

The injection of bleomycin in the BPH rats caused an atrophic change in the volume of the ventral lobes of prostate, glandular epithelium and fibromuscular tissue. In contrast, however,

the volume of microvessels decreased significantly in the bleomycin group in comparison to the BPH group (P \<0.01), hence its angioinhibitory effect. In addition, another interesting finding revealed by the comparison of alcohol and bleomycin was a significant difference in case of glandular epithelium. It indicated that alcohol had more potency to recover the increased volume of the epithelium in BPH rats.

The administration of finasteride in the BPH animals also incited an atrophic change in the prostate glandular epithelium as compared to the BPH group (P \<0.01). However, the increment of fibromuscular tissue and vessels volume in BPH+finasteride rats did not revert in comparison with the BPH group.

Qualitative evaluations {#sec3.2}
-----------------------

The results of microscopic and macroscopic qualitative evaluations are presented in [Figures 2](#f0002){ref-type="fig"} and [3](#f0003){ref-type="fig"} respectively. Regarding the control rats, the glandular tissue along with their pseudostratified columnar epithelium of varying heights could be seen. The columnar cells contained apical secretory granules. Some basal cells could also be found between the columnar cells for regeneration of the epithelium. The glandular tissue was surrounded by connective tissue and smooth muscle (fibromuscular stroma).

![Photomicrograph of the rat's prostate. **A.** Control group. The glandular tissue with their pseudostratified columnar epithelium, vessels and fibromuscular tissue surrounds the glands. No obvious structural change can be seen in the control group. **B.** In the testosterone treated rats, the epithelial hyperplasia formed the papillary projections in the glandular tissue can be seen. In addition, nuclear crowding and piling up could be observed. After ethanol **(C)** and bleomycin **(D)** injections in BPH rats, coagulative necrotic tissue associated with protein denaturation can be seen \[asterisk). **E.** Receiving finasteride ameliorated the prostatic changes due to BPH. **F.** No recovery were observed in the BPH animals treated with normal saline.](CEJU-70-01211-g002){#f0002}

![Photograph of the rat's ventral prostate. **A.** Control group. **B.** BPH, testosterone treated. **C.** BPH+ethanol. **D.** BPH+bleomycin **E.** BPH+finasteride. **F.** BPH+normal saline. The arrows indicate the ventral lobe of prostate. In **C** and **D** the necrotic tissue can be seen.](CEJU-70-01211-g003){#f0003}

As for the testosterone treated rats, the epithelial hyperplasia formed papillary projections in the glandular tissue. These papillary structures with their supporting stroma extended into the glandular lumen. In addition, nuclear crowding, occasional mitotic figures, piling up, and slight basophilia of the hyperplastic epithelium could be observed.

After applying ethanol and bleomycin in a case of experimental hypertrophy of the prostate, a coagulative necrotic tissue was observed which was generally lobular shaped. The necrotic tissue was associated with protein denaturation. Necrotic tissue could be seen even on the macroscopic scale.

DISCUSSION {#sec4}
==========

The present experimental study compared the intraprostatic injection of bleomycin (as a novel BPH treatment strategy) with intraprostatic injection of ethanol (95%) and oral administration of finasteride. The latter two methods were considered to be the classic medical treatments. While intraprostatic injection of different agents is considered a minimally invasive technique in lower urinary tract symptoms associated with benign prostatic hyperplasia, further studies on the efficacy of more novel agents are needed \[[@cit0012]\]. Mechanical devices such as Urolift are also emerging for patients who desire to save their sexual function or cannot tolerate surgery \[[@cit0013]\]. Recently, there has been an increasing interest in novel agents for intraprostatic injection. Although alcohol has been one of the most widely used injectable agents so far, Botolinum toxin also showed efficacy in symptom relief of BPH patients. Other agents such as NX-1207 and PRX302 have also been reported to have promising effects \[[@cit0014]\]. The present research applied unbiased stereological methods to obtain quantitative results. As was expected, a single injection of ethanol could effectively decrease all the hypertrophied structures except vessels. The results point to the likelihood of eliminating one third of prostatic volume in the PBH rats through injecting 10% of the average prostate volume of ethanol. Injection of the same amount of bleomycin could reduce the prostatic volume by 1/4. Despite this, there have been few studies on the detailed quantitative histological changes of the prostate after direct injection. Ethanol injection is an old concept which was first described in the early 1900s and since then it has attracted widespread interest \[[@cit0015]\]. Nonetheless, dehydrated ethanol injections have led to damages and extraprostatic leakages which in turn can result in grave consequences. Some of the common adverse effects of ethanol injection are dysuria, urinary retention, hematuria and rare cases of bladder necrosis \[[@cit0015]\]. Certain cases of ethanol injection have also been reported to cause complications such as liquefaction necrosis and urinary tract injury \[[@cit0015]\].

Therefore, this study introduced bleomycin as an alternative method. In the literature, there seems to be no reports about intraprostatic injection of bleomycin for the treatment of BPH, while there are several examples concerning other diseases. Direct intralesional injection of bleomycin for benign diseases such as hemangioma have been mentioned in the literature \[[@cit0016]\]. Additionally, it has been used in the treatment of orbital varicose veins as sclerotherapy \[[@cit0017]\]. Even in cases of abdominal simple cysts, in the kidneys and liver, for instance, bleomycin was used with hopeful results and a significant cyst volume reduction was reported \[[@cit0018]\].

In a survey that was published by Songaeng et al. \[[@cit0019]\], the authors retrospectively reviewed the experience in treating venous malformations using two sclerosing agents, ethanol 95% and bleomycin. In long term follow-up, they reported more positive results for the bleomycin treatment group \[[@cit0019]\]. According to their findings, not only did alcohol have a slightly higher success rate but also it required fewer therapy sessions. In addition, bleomycin had a lower complication rate and less swelling after surgery. They further claimed that bleomycin treatment might be better tolerated and is thus preferred over alcohol sclerotherapy \[[@cit0020]\]. Efficacy of bleomycin in reducing the size of lymphatic and venous malformation as well as fewer severe complications has given it priority over other sclerosing agents \[[@cit0021]\]. The present study is a preliminary animal experiment of the application of bleomycin and future work should be followed and completed in human research.

CONCLUSIONS {#sec5}
===========

Injection of alcohol and bleomycin as well as the treatment with finasteride while the volume of injection was approximately 10% of the ventral prostatic volume induced abolishment of 1/3, 1/4 and 1/5 of the gland respectively.
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